Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

XtalPi

Request full access

Artificial intelligence (AI) pharmaceutical firm

Shenzhen, ChinaFounded 2014Biotech & Life Sciences

At a glance

Status
Listed
Listing
IPO 2024

XtalPi in the Shenzhen ecosystem

Live from Dealroom

The XtalPi office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

16 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

Series B and later13 investors entered at this stage

Employees mapped 367 incl. 3 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 10 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Patents

Estimated portfolio value
$17M

341 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where XtalPi was the backer or acquirer, 2020–2026. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

19 deals across XtalPi's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        XtalPi's portfolio, mapped.

        Stage
        Period
        19 of 19 deals

        See XtalPi on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.